Evidence map›Paper›PMID 28710296›Full record

ArticleCirculation. Cardiovascular quality and outcomes2017

Priorities for Cardiovascular Outcomes Research: A Report of the National Heart, Lung, and Blood Institute's Centers for Cardiovascular Outcomes Research Working Group.

Prateeti Khazanie, Harlan M Krumholz, Catarina I Kiefe, Nancy R Kressin, Barbara Wells, Tracy Y Wang, Eric D Peterson

Abstract readConference Proceedings
PubMed Full text at PMC Publisher
In one paragraph

Article in Circulation. Cardiovascular quality and outcomes, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Introduction to Mammalian Genome special issue: cardiovascular disease in the Mammalian Genome.Mammalian genome : official journal of the International Mammalian Genome Society · 2023
    Article
  3. Article
  4. Article
  5. Article
  6. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Prateeti KhazanieFrom the Division of Cardiology, Department of Medicine, University of Colorado School of Medicine, Aurora (P.K.); Department of Medicine, Duke Clinical Research Institute, Duke University School of Medicine, Durham, NC (T.K.W., E.D.P.); Section of Cardiovascular Medicine, Department of Medicine, Yale School of Medicine, New Haven, CT (H.M.K.); Department of Health Policy and Management, Yale School of Public Health, Center for Outcomes Research and Evaluation, Yale New Haven Health, CT (H.M.K.); Department of Quantitative Health Sciences, University of Massachusetts Medical School, Worcester (C.I.K.); Department of Veterans Affairs, Boston University School of Medicine (N.R.K.); and National Heart, Lung, and Blood Institute, National Institutes of Health, Bethesda, MD (B.W.). prateeti.khazanie@ucdenver.edu.
Harlan M KrumholzFrom the Division of Cardiology, Department of Medicine, University of Colorado School of Medicine, Aurora (P.K.); Department of Medicine, Duke Clinical Research Institute, Duke University School of Medicine, Durham, NC (T.K.W., E.D.P.); Section of Cardiovascular Medicine, Department of Medicine, Yale School of Medicine, New Haven, CT (H.M.K.); Department of Health Policy and Management, Yale School of Public Health, Center for Outcomes Research and Evaluation, Yale New Haven Health, CT (H.M.K.); Department of Quantitative Health Sciences, University of Massachusetts Medical School, Worcester (C.I.K.); Department of Veterans Affairs, Boston University School of Medicine (N.R.K.); and National Heart, Lung, and Blood Institute, National Institutes of Health, Bethesda, MD (B.W.).
Catarina I KiefeFrom the Division of Cardiology, Department of Medicine, University of Colorado School of Medicine, Aurora (P.K.); Department of Medicine, Duke Clinical Research Institute, Duke University School of Medicine, Durham, NC (T.K.W., E.D.P.); Section of Cardiovascular Medicine, Department of Medicine, Yale School of Medicine, New Haven, CT (H.M.K.); Department of Health Policy and Management, Yale School of Public Health, Center for Outcomes Research and Evaluation, Yale New Haven Health, CT (H.M.K.); Department of Quantitative Health Sciences, University of Massachusetts Medical School, Worcester (C.I.K.); Department of Veterans Affairs, Boston University School of Medicine (N.R.K.); and National Heart, Lung, and Blood Institute, National Institutes of Health, Bethesda, MD (B.W.).
Nancy R KressinFrom the Division of Cardiology, Department of Medicine, University of Colorado School of Medicine, Aurora (P.K.); Department of Medicine, Duke Clinical Research Institute, Duke University School of Medicine, Durham, NC (T.K.W., E.D.P.); Section of Cardiovascular Medicine, Department of Medicine, Yale School of Medicine, New Haven, CT (H.M.K.); Department of Health Policy and Management, Yale School of Public Health, Center for Outcomes Research and Evaluation, Yale New Haven Health, CT (H.M.K.); Department of Quantitative Health Sciences, University of Massachusetts Medical School, Worcester (C.I.K.); Department of Veterans Affairs, Boston University School of Medicine (N.R.K.); and National Heart, Lung, and Blood Institute, National Institutes of Health, Bethesda, MD (B.W.).
Barbara WellsFrom the Division of Cardiology, Department of Medicine, University of Colorado School of Medicine, Aurora (P.K.); Department of Medicine, Duke Clinical Research Institute, Duke University School of Medicine, Durham, NC (T.K.W., E.D.P.); Section of Cardiovascular Medicine, Department of Medicine, Yale School of Medicine, New Haven, CT (H.M.K.); Department of Health Policy and Management, Yale School of Public Health, Center for Outcomes Research and Evaluation, Yale New Haven Health, CT (H.M.K.); Department of Quantitative Health Sciences, University of Massachusetts Medical School, Worcester (C.I.K.); Department of Veterans Affairs, Boston University School of Medicine (N.R.K.); and National Heart, Lung, and Blood Institute, National Institutes of Health, Bethesda, MD (B.W.).
Tracy Y WangFrom the Division of Cardiology, Department of Medicine, University of Colorado School of Medicine, Aurora (P.K.); Department of Medicine, Duke Clinical Research Institute, Duke University School of Medicine, Durham, NC (T.K.W., E.D.P.); Section of Cardiovascular Medicine, Department of Medicine, Yale School of Medicine, New Haven, CT (H.M.K.); Department of Health Policy and Management, Yale School of Public Health, Center for Outcomes Research and Evaluation, Yale New Haven Health, CT (H.M.K.); Department of Quantitative Health Sciences, University of Massachusetts Medical School, Worcester (C.I.K.); Department of Veterans Affairs, Boston University School of Medicine (N.R.K.); and National Heart, Lung, and Blood Institute, National Institutes of Health, Bethesda, MD (B.W.).
Eric D PetersonFrom the Division of Cardiology, Department of Medicine, University of Colorado School of Medicine, Aurora (P.K.); Department of Medicine, Duke Clinical Research Institute, Duke University School of Medicine, Durham, NC (T.K.W., E.D.P.); Section of Cardiovascular Medicine, Department of Medicine, Yale School of Medicine, New Haven, CT (H.M.K.); Department of Health Policy and Management, Yale School of Public Health, Center for Outcomes Research and Evaluation, Yale New Haven Health, CT (H.M.K.); Department of Quantitative Health Sciences, University of Massachusetts Medical School, Worcester (C.I.K.); Department of Veterans Affairs, Boston University School of Medicine (N.R.K.); and National Heart, Lung, and Blood Institute, National Institutes of Health, Bethesda, MD (B.W.).

Funding

Postdoctoral Training in Cardiovascular Clinical ResearchT32HL069749 · NHLBI · DUKE UNIVERSITY · PI MARK, DANIEL B · 2003 to 2023
$6.7M
Center for Health Insurance Reform, Cardiovascular Outcomes, and DisparitiesU01HL105342 · NHLBI · BOSTON MEDICAL CENTER · PI KRESSIN, NANCY R. · 2010 to 2014
$5.6M
Centers for Cardiovascular Outcomes ResearchU01HL107023 · NHLBI · DUKE UNIVERSITY · PI PETERSON, ERIC DAVID · 2010 to 2013
$2.6M
NHLBI NIH HHS L30 HL120199NHLBI NIH HHS T32 HL069749NHLBI NIH HHS U01 HL105342NHLBI NIH HHS U01 HL107023
6 · The paper itself

Abstract

The Centers for Cardiovascular Outcomes Research (CCORs) held a meeting to review how cardiovascular outcomes research had evolved in the decade since the National Heart, Lung, and Blood Institute 2004 working group report and to consider future directions. The conference involved representatives from governmental agencies, outcomes research thought leaders, and public and private healthcare partners. The main purposes of this meeting were to (1) advance collaborative high-yield, high-impact outcomes research; (2) identify priorities and barriers to important cardiovascular outcomes research; and (3) define future needs for the field. This report highlights the key topics covered during the meeting, including an examination of the recent history of outcomes research, an evaluation of the current academic climate, and a vision for the future of cardiovascular outcomes research.

Indexed as

Organizational ObjectivesCardiologyCost-Benefit AnalysisDelivery of Health CareHealth Care CostsHealth Services ResearchHumansInterdisciplinary CommunicationNational Heart, Lung, and Blood Institute (U.S.)Outcome Assessment, Health CarePatient-Centered CarePublic-Private Sector PartnershipsStakeholder ParticipationTranslational Research, BiomedicalUnited Statesdelivery of health carehealth services researchheartoutcome assessment (health care)United States

Identifiers

PMID28710296
PMCPMC7811766

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.